ESC Premium Access

Increased mortality despite successful multifactorial cardiovascular risk reduction in healthy men. 40-year follow-up of the Helsinki businessmen study intervention trial

Congress Presentation

About the speaker

Professor Timo Strandberg

Helsinki University Hospital, Helsinki (Finland)
0 follower

6 more presentations in this session

Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

Speaker: Associate Professor B. Mihaylova (Oxford, GB)

Thumbnail

Added predictive value of follow-up blood-pressure measurements after alteration of therapy on cardiovascular risk in patients with hypertension

Speaker: Ms N. Jaspers (Utrecht, NL)

Thumbnail

Optimizing outreach strategy to identify individuals at risk for diabetes and/or cardiovascular disease: a study of the Sodertalje municipality in Sweden

Speaker: Doctor B. Shahim (Stockholm, SE)

Thumbnail

Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Speaker: Professor M. Banach (Lodz, PL)

Thumbnail

Sex hormone-binding globulin, aging, and cardiovascular risk

Speaker: Ms E. Aribas (Rotterdam, NL)

Thumbnail

Access the full session

Controversies in cardiovascular risk assessment and prevention

Speakers: Professor T. Strandberg, Associate Professor B. Mihaylova, Ms N. Jaspers, Doctor B. Shahim, Professor M. Banach...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb